|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/18 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/18 | (2013.01) | ||
| A61P 25/28 | (2018.01) |
| (11) | Number of the document | 3402817 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17703491.5 |
| Date of filing the European patent application | 2017-01-10 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/012795 |
| Date | 2017-01-10 |
| (87) | Number | WO 2017/123517 |
| Date | 2017-07-20 |
| (30) | Number | Date | Country code |
| 201662279268 P | 2016-01-15 | US |
| (72) |
DEMATTOS, Ronald Bradley , US
LU, Jirong , US
TANG, Ying , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ANTI-N3-BETA-GLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |
| ANTI-N3-BETA-GLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF |